Successful treatment of persistent pulmonary hypertension of the newborn with bosentan

Acta Paediatrica, International Journal of Paediatrics

Volumn 98, Issue 10, 2009, Pages 1683-1685

  Nakwan, N ^a,a   Choksuchat, D ^a   Saksawad, R ^a   Thammachote, P ^a  

^a Hat Yai Hospital   (Thailand)

Author keywords

Bosentan; Newborn infant; Persistent pulmonary hypertension of the newborn

Indexed keywords

ADRENALIN; AMPICILLIN; BICARBONATE; BOSENTAN; DOBUTAMINE; DOPAMINE; FENTANYL; FRESH FROZEN PLASMA; GENTAMICIN; OXYGEN; SODIUM CHLORIDE;

APGAR SCORE; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CASE REPORT; DRUG DOSE REDUCTION; DRUG EFFICACY; DYSPNEA; ECHOCARDIOGRAPHY; EXTUBATION; FLUSHING; GESTATIONAL AGE; HEART FORAMEN OVALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HOSPITAL DISCHARGE; HUMAN; HYPOXEMIA; INTUBATION; LIVER TOXICITY; LUNG ARTERY PRESSURE; LUNG HEMORRHAGE; LUNG PARENCHYMA; MALE; MEAN ARTERIAL PRESSURE; NEWBORN; NEWBORN DISEASE; NEWBORN SEPSIS; OXYGEN SATURATION; OXYGEN SUPPLY; PATENT DUCTUS ARTERIOSUS; PEAK INSPIRATORY FLOW; PERSISTENT PULMONARY HYPERTENSION; PHYSICAL EXAMINATION; POSITIVE END EXPIRATORY PRESSURE; PRENATAL CARE; PRIORITY JOURNAL; SEDATION; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; THORAX RADIOGRAPHY; TREATMENT OUTCOME; UMBILICAL ARTERY; UMBILICAL VEIN; VAGINAL DELIVERY;

ANTIHYPERTENSIVE AGENTS; DEVELOPING COUNTRIES; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; MALE; RECEPTORS, ENDOTHELIN; RESPIRATION, ARTIFICIAL; SULFONAMIDES;

EID: 69749106616     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2009.01386.x     Document Type: Article

References (13)

1. Walsh M, Stork E. Persistent pulmonary hypertension of the newborn. Rational therapy bases on pathophysiology. Clin Perinatol 2001 28 : 609 627.
2. B-receptor gene expression in fetal pulmonary hypertension. Am J Physiol 1998 274 : L535 41.
3. Endo A, Ayusawa M, Minato M, Takada M, Takahashi S, Harada K. Endogenous nitric oxide and endothelin-1 in persistent pulmonary hypertension of the newborn. Eur J Pediatr 2001 160 : 217 222.
4. Rosenberg AA, Kennaugh J, Koppenhafer SL, Loomis M, Chatfield BA, Abman SH. Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J Pediatr 1993 123 : 109 114.
5. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002 346 : 896 903. (Pubitemid 34984638)
6. Galiè N, Rubin LJ, Hoeper MM, Jansa P, Al-hiti H, Meyer GMB, et al. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomized controlled trial. Lancet 2008 371 : 2093 2100.
7. Chen SJ, Chen YF, Meng QC, Durand J, Dicarlo VS, Oparil S. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J Appl Physiol 1995 79 : 2122 2131.
8. Maiya S, Hislop AA, Flynn Y, Haworth SG. Response to bosentan in children with pulmonary hypertension. Heart 2006 92 : 664 670.
9. Rugolotto S, Errico G, Beghini R, Ilic S, Richelli C, Padovani EM. Weaning of epoprostenol in a small infant receiving concomitant bosentan for severe pulmonary arterial hypertension secondary to bronchopulmonary dysplasia. Minerva Pediatr 2006 58 : 491 494.
10. Goissen C, Ghyselen L, Tourneux P, Krim G, Storme L, Bou P, et al. Persistent pulmonary hypertension of the newborn with transposition of the great arteries: successful treatment with bosentan. Eur J Pediatr 2008 167 : 437 440.
11. Ivy D, Parker T, Kinsella J, Abman SH. Endothelin A receptor blockade decreases pulmonary vascular resistance in premature lambs with hyaline membrane disease. Pediatr Res 1998 44 : 175 180.
12. D'Alto M, Vizza CD, Romeo E, Badagliacca R, Santoro G, Poscia R, et al. Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect. Heart 2007 93 : 621 625.
13. Apostolopoulou SC, Manginas A, Cokkinos DV, Rammos S. Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study. Heart 2007 93 : 350 354.